Ishita Drugs & Industries Reports Flat Performance, Receives 'Sell' Call from MarketsMOJO
Ishita Drugs & Industries, a microcap pharmaceutical company, reported a flat financial performance in the last quarter with a score of 0, compared to 2 in the previous quarter. MarketsMojo has given the company's stock a 'Sell' call based on its financial performance and market trends. Despite this, the company remains committed to providing affordable and high-quality medicines through its strong presence in domestic and international markets. Investors are advised to carefully evaluate the company's performance and future prospects before making any investment decisions.
On 12th November 2024, Ishita Drugs & Industries, a microcap pharmaceutical company, announced its financial results for the quarter ending September 2024. The company reported a flat performance with a score of 0, as compared to a score of 2 in the previous quarter. The company's stock has been given a 'Sell' call by MarketsMOJO, a leading financial analysis and research firm. This is based on the company's financial performance and market trends.
Ishita Drugs & Industries is a microcap company in the pharmaceutical and drugs industry. It specializes in the manufacturing and marketing of generic drugs, active pharmaceutical ingredients, and intermediates. The company has a strong presence in both domestic and international markets.
Despite the flat financial performance in the last quarter, Ishita Drugs & Industries remains committed to its goal of providing affordable and high-quality medicines to its customers. The company continues to invest in research and development to expand its product portfolio and cater to the growing demand for generic drugs.
Investors are advised to carefully consider the financial performance and market trends before making any investment decisions regarding Ishita Drugs & Industries. The company's stock call of 'Sell' by MarketsMOJO serves as a cautionary reminder to investors to thoroughly evaluate the company's performance and future prospects before investing.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
